Soleno Therapeutics, Inc. (SLNO) Misses Q3 EPS by 37c

Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q3 EPS of ($0.95), $0.37 worse than the analyst estimate of ($0.58).

For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• LeonaBio, Inc. (LONA) Tops Q2 EPS by 32c
• Paramount Global (PARA) Tops Q2 EPS by 175c